Related Experiment Video
Updated: Apr 19, 2026
07:44
Evaluation of Patients' Posture and Gait Profile After Lumbar Fusion Surgery by Video Rasterstereography and Treadmill Gait Analysis
Published on: March 23, 2019
19.0K
The Oswestry Spinal Risk Index (OSRI): an external validation study.
Christina Fleming1, Joseph F Baker2,3, Shane C O'Neill1
1Department of Orthopaedic Surgery, Mater Misericordiae University Hospital, Dublin, Ireland.
Summary
The Oswestry Spinal Risk Index (OSRI) accurately predicts survival in patients with metastatic spinal disease. This validation study confirms OSRI as a valuable tool for managing spinal tumors.
Area of Science:
- Oncology
- Spinal Surgery
- Biostatistics
Background:
- Metastatic spinal disease presents complex management challenges.
- Accurate survivorship prediction is crucial for treatment planning.
- The Oswestry Spinal Risk Index (OSRI) was developed to aid in this prediction.
Purpose of the Study:
- To externally validate the Oswestry Spinal Risk Index (OSRI) for predicting survivorship.
- To assess the utility of OSRI as an adjunct in managing metastatic spinal disease.
Main Methods:
- A cohort of 121 patients with metastatic spinal disease was analyzed.
- Actual survivorship was calculated based on tumor type and Karnofsky Performance Score.
- Patient survival data were compared against OSRI predictions.
Main Results:
- The study cohort comprised 45.5% females with a mean age of 61.5 years.
- Breast and prostate cancers were the most common primary tumors.
- Actual survival strongly correlated with OSRI-predicted survivorship (r = 0.798, p = 0.001).
Conclusions:
- The Oswestry Spinal Risk Index (OSRI) is a user-friendly scoring system.
- External validation demonstrated a strong correlation between predicted and actual survivorship.
- OSRI serves as a beneficial adjunct in managing patients with metastatic spinal disease.
